- Active not recruitingPHASE2
Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.
This study is for women with advanced womb cancer that has returned or worsened after chemotherapy. It tests a new drug called retifanlimab, sometimes alone and sometimes with other medicines, to see how safe and effective they are.
For: Endometrial CancerUnited States · Belgium · France - RecruitingPHASE2
Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells
This study is looking at a drug called pemigatinib for solid cancers that have a specific change (alteration) in a gene called FGFR. It's for people whose cancer has come back or spread, and it aims to see if pemigatinib can help shrink or control these cancers.
For: Solid Tumor, MiscellaneousFrance